Main > > >ANESTHESIA. *
3860+ MRI IntraVenous Infusion Pump System.
MRI: Magnetic Resonance Imaging.
USA Approval Date: 2016. 12.19.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
AirWay Management. Enhanced Direct Laryngoscope. (EDL). (I)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
AirWay Management. Video Laryngoscopes.
(U>D).
(*) Company; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2018. 04.02.
AirWay Management. Video Laryngoscopes.
(U>V).
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
Dexmedetomidine.HCl in 0.9% NaCl Injec-
tion.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
FosPropofol DiNa Injection.
- About FosPropofol DiNa Inj.:
proprietary water-soluble prodrug of
propofol that, after intravenous
injection, is rapidly converted by an
enzyme (alkaline phosphatase) in the
body into propofol
Sedative/Hypnotic Agent
USA Approval Date: 2008. 12.15.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
Information Management System. (U)
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 05.17.
Lidocaine Gel 4%.
Aesthetic Procedures.
USA Launch Date: 2018. 04.11.
(*) Company; USA Patent APP. & Web-
Site Available on Request.
UpDate: 2018. 04.12.
Lidocaine Ointment 5%. Generic. (T)
USA Approval Date: 2017. 09.27.
(*) Company Available on Request.
UpDate: 2018. 04.02.
Lidocaine Ointment 5%. Generic. (U)
CA Approval Date : 2016. 10.05.
USA Approval Date: 2016. 02.02.
(*) Company Available on Request.
UpDate: 2018. 04.02.
Lidocaine.HCl Injection.
(*) Company : Fresenius Kabi USA.
TradeMark: Xylocaine.
UpDate: 2018. 04.02.
Lidocaine.HCl Topical Solution. Generic.
CA Approval Date: 2016. 09.30.
(*) Company Available on Request.
UpDate: 2018. 04.02.
Malignant Hyperthermia. TREAT.:
Dantrolene Na for Injectable Suspension
USA Approval Date: 2014. 08.06.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
Mepivacaine.HCl Injection.
(*) Company : Fresenius Kabi USA
TradeMark: Polocaine
Web-Site :
products.fresenius-kabi.us/product-
151.html
UpDate: 2018. 04.02.
Midazolam.HCl Injection.
(*) Company: Fresenius Kabi USA.
UpDate: 2017. 04.19.
Midazolam.HCl Oral Liquid for Pediatrics
6 months - 17 years.
EU Approval Date: 2018. 09.12.
(*) Company : Primex Pharmaceuticals.
TradeMark: Ozalin
Web-Site : www.primexpharma.com
UpDate: 2018. 09.14.
Midazolam+Ketamine+Ondansetron SubLingual Form.
Availability: Yes.
Indications: Ophthalmo.>Cataract Surgery
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 03.28.
Pressure Sensing Instrument.
USA Approval Date: 2017. 06.12.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
Propofol Injectable Emulsion. Brand.
(*) Company : Fresenius Kabi USA.
TradeMark: Diprivan.
UpDate: 2017. 04.19.
Propofol Injectable Emulsion. Generic.
USA Launch Date: 2019. 01.24.
(*) Company: Dr. Reddy s Laboratories
Ltd
UpDate: 2019. 01.25.
Ropivacaine Infusion.
Indication: PostSurgery Pain.
AU Approval Date: 2017. 03.14.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
Ropivacaine Injection.
(*) Company : Fresenius Kabi USA.
Patents : Expired.
TradeMark: Naropin.
Web-Site : www.naropin-us.com/
UpDate: 2018. 04.02.
Sugammadex Injection.
CycloDextrin Deriv.
- Indication:
reversal of neuromuscular blockade
induced by rocuronium bromide and
vecuronium bromide in adults
undergoing surgery
USA Approval Date: 2015. 12.15.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
UltraSound System.
- Help Apply Spinal & Epidural
anesthesia with automated detection of
epidural location and depth.
CA Approval Date : 2017. 04.25.
USA Approval Date: 2015. 06.01.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.
>ANESTHESIA. *'s products
This section has no products